(Reuters) -Danaher Corp said on Monday it would buy medical equipment vendor Abcam Plc in a deal valued at $5.7 billion including debt, to expand its portfolio of biomedical services.
Danaher will pay $24 per share in cash, a 2.7% premium to Abcam’s last closing price.
Abcam shares rose 3.9% higher on Friday after Reuters reported Danaher was in the lead to acquire the company.
Danaher, one of the world’s largest suppliers of diagnostic tools with a market value of $190 billion, has turned to dealmaking to expand in the sector. Abcam’s antibody and reagent solutions could help Danaher win more and bigger contracts with some customers.
(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)
